HomeProductsBuilding BlocksHeterocyclic ScaffoldsAliphatic HeterocyclesCphpc
Chemical structure of CAS 224624-80-0

Cphpc

In Stock•Starting at $8 for 1 mg•Purity ≥ 97%
CAS No.224624-80-0
MDL No.MFCD09970762
MFC16H24N2O6
MW340.37
InChI KeyHZLAWYIBLZNRFZ-VXGBXAGGSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg97%$8In Stock
5 mg97%$11In Stock
10 mg97%$15In Stock
100 mg97%$68In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.224624-80-0
Product NameCphpc

Biological Targets

APCS

Associated Conditions

HIV infection·amyloidosis·primary systemic amyloidosis
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Genetic evidence for serum amyloid P component as a drug target for treatment of neurodegenerative disorders.

medRxiv : the preprint server for health sciences • 2023
PMID: 37645746PMC: PMC10462209DOI: 10.1101/2023.08.15.23293564

An observational, non-interventional study for the follow-up of patients with amyloidosis who received miridesap followed by dezamizumab in a phase 1 study.

Orphanet journal of rare diseases • Vol. 17, Issue 1 • 2022
PMID: 35810311PMC: PMC9271258DOI: 10.1186/s13023-022-02405-7

Light chain (AL) amyloidosis: update on diagnosis and management.

Journal of hematology & oncology • Vol. 4 • 2011
PMID: 22100031PMC: PMC3228694DOI: 10.1186/1756-8722-4-47

Immunoradiometric assay for human serum amyloid P component.

Journal of immunological methods • Vol. 371, Issue 1-2 • 2011
PMID: 21708157DOI: 10.1016/j.jim.2011.06.010

Documentation

Similar Products